Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks
Authors
Keywords
Outbreak response, Campaigns, Circulating vaccine-derived poliovirus, Inactivated poliovirus vaccine, Oral poliovirus vaccine
Journal
VACCINE
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-03-29
DOI
10.1016/j.vaccine.2022.03.027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability
- (2020) Catherine Daly et al. VACCINE
- Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral poliovirus vaccine
- (2020) G. R. Macklin et al. SCIENCE
- Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020
- (2020) Mary M. Alleman et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
- (2020) Ananda S Bandyopadhyay et al. LANCET INFECTIOUS DISEASES
- Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial
- (2019) Cynthia J Snider et al. LANCET
- Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis
- (2019) Grace R Macklin et al. LANCET INFECTIOUS DISEASES
- Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial
- (2018) Khalequ Zaman et al. LANCET INFECTIOUS DISEASES
- Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations
- (2018) Radboud J. Duintjer Tebbens et al. RISK ANALYSIS
- Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan
- (2018) Ali Faisal Saleem et al. VACCINE
- Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 — Syria, 2017–2018
- (2018) Chukwuma Mbaeyi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan
- (2017) Ali F Saleem et al. JOURNAL OF INFECTIOUS DISEASES
- Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America
- (2017) Eduardo Lopez-Medina et al. VACCINE
- Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan
- (2017) Ali Faisal Saleem et al. VACCINE
- Fractional-Dose Inactivated Poliovirus Vaccine Campaign — Sindh Province, Pakistan, 2016
- (2017) Aslam Pervaiz et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame
- (2016) Radboud J. Duintjer Tebbens et al. BMC INFECTIOUS DISEASES
- Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial
- (2016) Edwin J Asturias et al. LANCET
- Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial
- (2016) Xavier Sáez-Llorens et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
- (2016) Ed Clarke et al. Lancet Global Health
- Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign — Telangana State, India, June 2016
- (2016) Sunil Bahl et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial
- (2015) Roland W Sutter et al. LANCET
- Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial
- (2015) Concepción F Estívariz et al. LANCET INFECTIOUS DISEASES
- Immunogenicity of poliovirus vaccines in chronically malnourished infants: A randomized controlled trial in Pakistan
- (2015) Ali Faisal Saleem et al. VACCINE
- Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial
- (2015) Abhijeet Anand et al. VACCINE
- Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in Cuba
- (2015) Sonia Resik et al. VACCINE
- Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013
- (2014) L M Shulman et al. Eurosurveillance
- Progress Toward Global Interruption of Wild Poliovirus Transmission, 2010-2013, and Tackling the Challenges to Complete Eradication
- (2014) S. G. F. Wassilak et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysis
- (2014) Nicholas C. Grassly JOURNAL OF INFECTIOUS DISEASES
- Vaccine-Derived Polioviruses
- (2014) C. C. Burns et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden
- (2014) L. R. Platt et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial
- (2014) Jacob John et al. LANCET
- Efficacy of inactivated poliovirus vaccine in India
- (2014) H. Jafari et al. SCIENCE
- Priming after a Fractional Dose of Inactivated Poliovirus Vaccine
- (2013) Sonia Resik et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poliovirus vaccination options for achieving eradication and securing the endgame
- (2013) Concepción F Estívariz et al. Current Opinion in Virology
- Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trial
- (2011) Concepción F Estívariz et al. LANCET INFECTIOUS DISEASES
- Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trials
- (2011) T. Jacob John et al. VACCINE
- Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial
- (2010) Roland W Sutter et al. LANCET
- Monovalent Type 1 Oral Poliovirus Vaccine in Newborns
- (2008) Nasr El-Sayed et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started